PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $121,439 | +839.5% | 11,756 | +1092.3% | 0.00% | – |
| Q2 2023 | $12,926 | +107616.7% | 986 | -7.6% | 0.00% | – |
| Q1 2023 | $12 | -92.9% | 1,067 | -94.7% | 0.00% | -100.0% |
| Q4 2022 | $170 | -99.6% | 20,207 | +787.1% | 0.01% | +600.0% |
| Q3 2022 | $38,000 | -50.6% | 2,278 | -56.6% | 0.00% | -50.0% |
| Q2 2022 | $77,000 | -68.6% | 5,252 | -46.9% | 0.00% | 0.0% |
| Q1 2022 | $245,000 | +245.1% | 9,891 | +346.3% | 0.00% | +100.0% |
| Q4 2021 | $71,000 | +108.8% | 2,216 | +140.6% | 0.00% | 0.0% |
| Q3 2021 | $34,000 | -84.8% | 921 | -81.9% | 0.00% | -83.3% |
| Q2 2021 | $224,000 | +119.6% | 5,075 | +127.1% | 0.01% | +200.0% |
| Q1 2021 | $102,000 | +500.0% | 2,235 | +827.4% | 0.00% | +100.0% |
| Q4 2020 | $17,000 | – | 241 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $1,494,000 | 12.13% |
| Miura Global Management | 595,000 | $14,762,000 | 4.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,695,341 | $91,681,000 | 2.05% |
| Millrace Asset Group, Inc. | 78,859 | $1,956,000 | 1.42% |
| NEXT CENTURY GROWTH INVESTORS LLC | 436,034 | $10,818,000 | 1.08% |
| Novo Holdings A/S | 410,155 | $10,176,000 | 0.54% |
| PURA VIDA INVESTMENTS, LLC | 589,722 | $14,631,000 | 0.47% |
| Rock Springs Capital Management LP | 702,400 | $17,427,000 | 0.44% |
| RTW INVESTMENTS, LP | 798,255 | $19,805,000 | 0.41% |
| Regis Management CO LLC | 82,070 | $2,036,000 | 0.36% |